Director sold ~$527K of Exelixis
Scheduled in advanceEXEL · NASDAQ · Biotechnology
Director sold ~$527K of Exelixis
Scheduled in advanceDirector sold ~$492K of Exelixis
Scheduled in advanceDirector sold ~$198K of Exelixis
Scheduled in advanceOfficer sold ~$2.19M of Exelixis
Automatic saleOfficer sold ~$1.6M of Exelixis
Automatic saleOfficer sold ~$333K of Exelixis
Scheduled in advanceDirector sold ~$2.74M of Exelixis
Automatic saleDirector sold ~$949K of Exelixis
Automatic saleDirector sold ~$374K of Exelixis
Automatic saleOfficer sold ~$2.13M of Exelixis
Automatic saleOfficer sold ~$1.32M of Exelixis
Automatic saleDirector sold ~$4.38M of Exelixis
Scheduled in advanceDirector sold ~$1.96M of Exelixis
Automatic saleDirector sold ~$1.84M of Exelixis
Automatic saleDirector sold ~$887K of Exelixis
Automatic saleOfficer sold ~$2.82M of Exelixis
Automatic saleDirector sold ~$929K of Exelixis
Automatic saleOfficer sold ~$822K of Exelixis
Scheduled in advanceDirector sold ~$396K of Exelixis
Automatic saleDirector sold ~$169K of Exelixis
Scheduled in advanceOfficer sold ~$133K of Exelixis
Automatic saleStock since the trade +36.5% · S&P 500 +14.8% · to Oct 5
A board member of Exelixis paid $1.19M out of pocket for Exelixis shares.
Patrick J. Haley · Traded Nov 20, 2025 · largest single filing ~$987K
Nov 20, 2025~$987K · 24K sh @ $41.93
DetailsOfficial recordNov 20, 2025~$445K · 11K sh @ $41.77
DetailsOfficer sold ~$1.19M of Exelixis
Automatic saleOfficer sold ~$421K of Exelixis
Automatic saleDirector sold ~$4.36M of Exelixis
Automatic saleOfficer sold ~$2.06M of Exelixis
Automatic saleDirector sold ~$789K of Exelixis
Automatic saleDirector sold ~$243K of Exelixis
Automatic sale